2015
DOI: 10.1016/j.ijsu.2015.07.009
|View full text |Cite
|
Sign up to set email alerts
|

Xenograft bioprosthetic heart valves: Past, present and future

Abstract: The transplantation (implantation) of xenograft heart valves into humans has been carried out for >50 years. There has been considerable research into making this form of xenotransplantation successful, though it is not perfect yet. We review the understanding of the immune response to xenograft heart valves. Important steps in the history include understanding (i) the importance of glutaraldehyde in decreasing the immune response and (ii) the relationship between calcification (which is the main problem leadi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
118
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 139 publications
(121 citation statements)
references
References 37 publications
(34 reference statements)
2
118
0
1
Order By: Relevance
“…Biological valves still have poor long‐term durability due to calcification and mechanical failure. Bovine pericardial tissue and aortic porcine valves (stented or unstented) fixed with glutaraldehyde are used to construct heart valves in which the design characteristics are the main differences between heart valve manufacturers . So it is necessary to select a more appropriate tissue, mechanically and histologically, which can improve the long‐term durability of these valves.…”
Section: Introductionmentioning
confidence: 99%
“…Biological valves still have poor long‐term durability due to calcification and mechanical failure. Bovine pericardial tissue and aortic porcine valves (stented or unstented) fixed with glutaraldehyde are used to construct heart valves in which the design characteristics are the main differences between heart valve manufacturers . So it is necessary to select a more appropriate tissue, mechanically and histologically, which can improve the long‐term durability of these valves.…”
Section: Introductionmentioning
confidence: 99%
“…Cross-linking with GA is employed to increase the strength and durability of bioprosthetics and provides protection from enzymatic degradation [15]. However, conventional GA treatment decreases pliability (increased stiffness) of the bioscaffolds [15,16] and is associated with an increased risk for calcification and graft failure [8]. CardioCel is therefore crosslinked via a unique process based on an ultra-low concentration of monomeric GA, which provides thorough cross-linking without being prone to calcification [14,17].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, the calcification process in children is accelerated compared with adults, and bioprosthetics have a much shorter lifespan in young patients [8].…”
Section: Introductionmentioning
confidence: 99%
“…Alternative donor sources, such as scaffolds derived from xenografts, may be promising substitutes [34]; however, this strategy comes with its own hurdles, such as the difficulties of ensuring that the xenograft is a suitable anatomical substitute, the potential for zoonotic infections, and the possibility for long-term scaffold rejection due to xenospecific epitopes [35].…”
Section: Organ Scaffoldsmentioning
confidence: 99%